Print

Print


*Apologies for cross posting*


American Society for Neurochemistry chooses Portland Press Limited to publish 
its new journal ASN NEURO. 

ASN NEURO will be launched in 2009 as an Open Access journal to further the 
Society's mission to advance, promote, support, encourage and facilitate 
communication among investigators in the cellular and molecular neuroscience 
community.

ASN have appointed a distinguished member of the international neuroscience 
community as the first Editor-in-Chief: Professor Anthony T. Campagnoni, who 
holds the Coates Chair in Neuroscience, Semel Institute for Neuroscience & 
Human Behaviour, UCLA, has agreed to provide the editorial leadership for this 
exciting new addition to scholarly publishing.

ASN NEURO will develop a range of specific knowledge environments to 
represent the broader scope and aims of the ASN, namely: Cell, Molecular and 
Developmental Neurobiology; Cell Signalling and Neurophysiology: Nervous 
System Metabolism; Architecture of the Nervous System; Neurodegeneration 
and Neuroprotection; Biology of Glia; Brain Injury and Repair; Inflammation and 
Immune Response in the Nervous System.

"We look forward to developing a successful publishing partnership with the 
ASN and Professor Campagnoni, and are delighted that ASN have selected 
Portland Press to help them to realise their vision for ASN NEURO” said Rhonda 
Oliver, Managing Director of Portland Press Limited.

"The ASN Officers and Council are excited by the innovative online open 
access formats that Portland Press is developing for ASN NEURO.  We are 
confident that with Professor Campagnoni's leadership, ASN NEURO will 
become a strong new voice, representing the traditional themes of our Society 
while offering novel possibilities for rapid, open access publication of complex 
data in multiple, media formats" said Monica Carson, President of ASN.

“I am delighted to be asked by the ASN to serve as the first Editor-in-Chief of 
ASN NEURO. This new online journal will present many advantages to authors: 
very rapid publication, free colour figures, personal copyright of papers, and 
fewer constraints than print journals in the way information is presented. I 
look forward to the challenges of launching this new journal devoted to 
publishing high-quality manuscripts reporting important advances in all areas of 
Neuroscience” said Professor Anthony Campagnoni

All inquiries concerning the future launch of ASN NEURO should be directed to 
[log in to unmask] or sign up for further information at 
www.asnneuro.org.

Additional information

Founded in 1969, the ASN is a thriving membership-based learned society. 
Please visit www.asneurochem.org for more information on ASN.

Professor Campagnoni is an internationally known expert in the molecular 
biology of myelination.  He has been a member of the ASN for over 35 years, 
attending almost all of its meetings during that period.  His primary research 
interests have been in the molecular and developmental regulation of 
oligodendrocyte function and myelination.  Most recently he has been actively 
studying alternative functions of the myelin protein genes, particularly those 
of a second family of proteins expressed by the myelin basic protein gene in 
neurons, glia and cells of the immune system.  The goal of his laboratory is to 
understand the function of these MBP gene products in the immune and 
nervous system.

Portland Press Limited is the not-for-profit, wholly owned subsidiary of the 
Biochemical Society. It publishes a number of highly regarded journals in the 
cellular and molecular life sciences and was the winner of the 2007 ALPSP 
Charlesworth Award for best online journal in 2007. For further details on 
Portland Press Limited, please visit www.portlandpress.com.

 
Kerry Cole
Head of Marketing and Sales
Portland Press Ltd / The Biochemical Society
Commerce Way
Colchester CO2 8HP
United Kingdom
Tel: +44 (0)1206 796351
Fax: +44 (0)1206 798650

lis-e-resources is a UKSG list - http://www.uksg.org/serials
UKSG groups also available on Facebook and LinkedIn